Table 2.
Characteristics | Disease-Free survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
HR(95% CI) | P | HR(95% CI) | P | HR(95% CI) | P | HR(95% CI) | P | |
GPS | ||||||||
0 | 1 | 0.01* | 1 | 0.03* | 1 | 0.02* | 1 | 0.02* |
1 | 0.7(0.4–0.9) | 0.8(0.5–0.9) | 0.8(0.5–0.9) | 0.8(0.4–0.9) | ||||
2 | 0.5(0.2–0.8) | 0.6(0.2–0.8) | 0.5(0.3–0.8) | 0.5(0.2–0.9) | ||||
CYFRA21-1 (>3.3 ng/ml) | 0.6(0.5–0.9) | 0.03* | 0.7(0.5–1.0) | 0.08 | 0.7(0.3–0.9) | 0.04* | 0.8(0.5–1.0) | 0.07 |
CEA (>5 ng/ml) | 0.7(0.4–1.1) | 0.13 | 0.7(0.5–1.2) | 0.17 | 0.8(0.5–1.1) | 0.19 | 0.8(0.6–1.3) | 0.19 |
TPS (>80 U/l) | 0.7(0.5–0.9) | 0.04* | 0.7(0.5–1.1) | 0.12 | 0.8(0.5–1.0) | 0.05 | 0.8(0.4–1.1) | 0.13 |
*P < 0.05.